United States · Retail startup

Eponym

Eponym is a New York-based eyewear company that specializes in helping brands design, manufacture, and distribute their own eyewear collections.

Funding reportedLast round: Series A

RetailNew York, United States

About Eponym

Eponym is a New York-based eyewear company that specializes in helping brands design, manufacture, and distribute their own eyewear collections.

The company partners with brands throughout the entire process, from design and fabrication to launch, providing a collaborative platform for design, distribution, and digital experiences. Eponym focuses on brand-to-market eyewear development, creating custom branded eyewear lines that include prescription eyewear, sunglasses, readers, and reading glasses. The company has collaborated with notable brands such as Classic Specs, Ottavo, alice + olivia eyewear, Jason Wu Eyewear, Steven Alan Optical, and Billy Reid Eyewear, showcasing its commitment to working with innovative brands in the eyewear industry.

What company datasets say Eponym raised

Funding, as reported

Reported in all$13Min dollars
Rounds4
Last roundSeries A
Last round size$7.0M
Last round dateAug 2016
Investors listed9

The company, in detail

What they build

Known for

brand partnershipfashionluxury goodsconsumersitalian design influencebrand awarenesscollaborationvintage-inspired framesopticaldesign and fabricationinformation technology & servicescustommarket entry supportinformation technologybespoke eyeweareyewear design

Built with from their website

Google Tag ManagerOtter BlocksWordPress.orgYouTubeGoogle WorkspaceViewport MetaSiteGroundGoogle Cloud HostingGoogle MeetPriority Hints

+8 more

CAPTCHAGoogle Font APIMySQLPrimeNGMobile FriendlySmart Slider 3BootstrapAmazon Route 53

Sector
Retail
Industry code
NAICS 33991, 339115, 54142, SIC 3911
Region
New York
Revenue
$2.8M a year, as listed
Full record
Every detail in the company directory

Retail in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Eponym in front of investors. Or tell us what we have wrong.